Search results
Precigen Reports First Quarter 2024 Financial Results and Business Updates
WRBL Columbus· 3 days ago– Pivotal Phase 2 study data of PRGN-2012 for the treatment of patients with recurrent respiratory papillomatosis to be presented at the 2024 ASCO Annual Meeting as a late-breaking oral presentation ...
Earnings call: Belite Bio highlights progress in key drug trials, Q1 financials By Investing.com
Investing.com· 2 days agoDespite reporting increased research and development expenses and a net loss for the quarter, Belite...
A Way Home: Homelessness is a moment in time, not an identity
Pasadena Star-News· 6 days agoWe are siblings and parents, grandparents, artists, teachers, philosophers, appreciators, and lovers...
Washington County Grand Jury
The Marietta Times· 2 days agoThe Washington County Grand Jury indicted 24 people this week on a variety of charges. The following indictments were issued: * Marcus Evan MacAuley, 18, Marietta, third-degree strangulation ...
Sober minded
Deseret News via Yahoo News· 5 days agoAccording to the National Council on Alcoholism and Drug Dependence, more than half of all adults have a family history of alcohol abuse or problem...
Kodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer...
The Yuma Sun· 4 days agoKodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat a broad spectrum of retinal diseases ...
Anti-Money Laundering and Sanctions Whistleblower Reward Program is a Force-Multiplier to Detect and...
The National Law Review· 4 days agoAnti-Money Laundering and Sanctions Whistleblower Program
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 4 days ago— Almost half a million people diagnosed each year across the globe — — Collaboration based on synergistic potential of inhibiting angiogenesis and tumor-associated macrophages with HUTCHMED’s surufatinib and anti-PD-1 activity with Hengrui’s
Indigenous advocates work to combat fake sober living homes in Arizona
Arizona Mirror via Yahoo News· 4 days agoJade Lara was five months pregnant in January 2022 when she arrived at a group home in San Tan...
Carisma Therapeutics begins trial for novel cancer therapy By Investing.com
Investing.com· 1 day agoCarisma Therapeutics Inc. (NASDAQ: CARM), a biopharmaceutical company, announced today the...
